Minimal dose requirements for nasal mupirocin and its role in the control of epidemic MRSA
- 30 September 1991
- journal article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 19, 35-40
- https://doi.org/10.1016/0195-6701(91)90201-i
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mupirocin for the reduction of colonization of internal jugular cannulae—a randomized controlled trialJournal of Hospital Infection, 1990
- The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopaedic unitJournal of Hospital Infection, 1990
- Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreakJournal of Antimicrobial Chemotherapy, 1988
- An outbreak of infection with a methicillin-resistant Staphylococcus aureus in a special care baby unit: value of topical mupirocin and of traditional methods of infection controlJournal of Hospital Infection, 1987
- The carrier state: methicillin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 1986
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986
- Gentamicin-methicillin-resistant Staphylococcus aureus: epidemiology and containment of an outbreakJournal of Hospital Infection, 1986
- Nasal acquisition of Staphylococcus aureus in a subdivided and mechanically ventilated ward: endemic prevalence of a single staphylococcal strainEpidemiology and Infection, 1970
- Staphylococcal infection in thoracic surgery: experience in a subdivided wardEpidemiology and Infection, 1966
- HEALTHY CARRIAGE OF STAPHYLOCOCCUS AUREUS : ITS PREVALENCE AND IMPORTANCEMicrobiology and Molecular Biology Reviews, 1963